CD2AP and Alzheimer disease: To investigate whether Cd2ap deletion accelerated the onset of AD by increasing Aβ accumulation, we performed ELISA to measure the levels of RIPA-soluble and RIPA-insoluble (formic-acid soluble) Aβ.